Menu
GeneBe

rs17639446

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000088.4(COL1A1):c.859-14T>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,614,024 control chromosomes in the GnomAD database, including 9,749 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.076 ( 595 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9154 hom. )

Consequence

COL1A1
NM_000088.4 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.645
Variant links:
Genes affected
COL1A1 (HGNC:2197): (collagen type I alpha 1 chain) This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-50196542-A-C is Benign according to our data. Variant chr17-50196542-A-C is described in ClinVar as [Benign]. Clinvar id is 254951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-50196542-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL1A1NM_000088.4 linkuse as main transcriptc.859-14T>G splice_polypyrimidine_tract_variant, intron_variant ENST00000225964.10
COL1A1XM_005257058.5 linkuse as main transcriptc.859-14T>G splice_polypyrimidine_tract_variant, intron_variant
COL1A1XM_005257059.5 linkuse as main transcriptc.859-14T>G splice_polypyrimidine_tract_variant, intron_variant
COL1A1XM_011524341.2 linkuse as main transcriptc.859-14T>G splice_polypyrimidine_tract_variant, intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL1A1ENST00000225964.10 linkuse as main transcriptc.859-14T>G splice_polypyrimidine_tract_variant, intron_variant 1 NM_000088.4 P1
COL1A1ENST00000485870.1 linkuse as main transcriptn.54T>G non_coding_transcript_exon_variant 1/23
COL1A1ENST00000495677.1 linkuse as main transcriptn.586-14T>G splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0764
AC:
11630
AN:
152134
Hom.:
595
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0225
Gnomad AMI
AF:
0.207
Gnomad AMR
AF:
0.0927
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0270
Gnomad FIN
AF:
0.0419
Gnomad MID
AF:
0.172
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.0956
GnomAD3 exomes
AF:
0.0782
AC:
19663
AN:
251474
Hom.:
1059
AF XY:
0.0795
AC XY:
10811
AN XY:
135910
show subpopulations
Gnomad AFR exome
AF:
0.0217
Gnomad AMR exome
AF:
0.0615
Gnomad ASJ exome
AF:
0.142
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.0303
Gnomad FIN exome
AF:
0.0453
Gnomad NFE exome
AF:
0.117
Gnomad OTH exome
AF:
0.0961
GnomAD4 exome
AF:
0.105
AC:
153074
AN:
1461772
Hom.:
9154
Cov.:
39
AF XY:
0.103
AC XY:
74727
AN XY:
727204
show subpopulations
Gnomad4 AFR exome
AF:
0.0203
Gnomad4 AMR exome
AF:
0.0648
Gnomad4 ASJ exome
AF:
0.138
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0320
Gnomad4 FIN exome
AF:
0.0482
Gnomad4 NFE exome
AF:
0.120
Gnomad4 OTH exome
AF:
0.102
GnomAD4 genome
AF:
0.0764
AC:
11627
AN:
152252
Hom.:
595
Cov.:
32
AF XY:
0.0721
AC XY:
5367
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.0224
Gnomad4 AMR
AF:
0.0926
Gnomad4 ASJ
AF:
0.136
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.0270
Gnomad4 FIN
AF:
0.0419
Gnomad4 NFE
AF:
0.114
Gnomad4 OTH
AF:
0.0951
Alfa
AF:
0.0935
Hom.:
196
Bravo
AF:
0.0794

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 26, 2017- -
Osteogenesis imperfecta Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Ehlers-Danlos syndrome, arthrochalasia type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Infantile cortical hyperostosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Osteogenesis imperfecta type I Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
Cadd
Benign
15
Dann
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17639446; hg19: chr17-48273903; COSMIC: COSV56806929; COSMIC: COSV56806929; API